Forward Pharma A/S (FWPAY) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Copenhagen, Denmark. 현재 CEO는 Claus Bo Søndergaard Svendsen.
FWPAY 을(를) 보유 IPO 날짜 2014-10-15, 4 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $7.45M.
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
